Canopy Growth

Canopy Growth Introduces Spectrum Therapeutics

Retrieved on: 
Tuesday, May 7, 2019
Entheogens, Euphoriants, Medicine, Medicinal plants, Health, Antiemetics, Psychoactive drugs, Appetite stimulants, Canopy Growth, Dronabinol, Cannabinoid, CGC

SMITHS FALLS, ON, May 7, 2019 /PRNewswire/ -Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3"), a European leader in cannabinoid-based medical therapies.

Key Points: 
  • SMITHS FALLS, ON, May 7, 2019 /PRNewswire/ -Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3"), a European leader in cannabinoid-based medical therapies.
  • Dronabinol, while integrated into the Spectrum Therapeutics commercial offering, will continue to be marketed under C3's established and recognized branding, Bionorica Ethics.
  • "We've always been a company that provides more than medical cannabis to our patients," commented Dr. Mark Ware, Chief Medical Officer, Canopy Growth.
  • Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Marcato To Vote Against Acreage Holdings' Value-Destroying Proposed Transaction With Canopy Growth Corporation

Retrieved on: 
Monday, May 6, 2019
Financial markets, Stock market, Cannabis, Economy, Equity securities, Canopy Growth, Acreage Holdings, Shareholder, Share, Marcato

SAN FRANCISCO, May 6, 2019 /PRNewswire/ -- Marcato Capital Management LP ("Marcato"), a San Francisco-based investment manager which manages funds that beneficially own approximately 2.7% of the outstanding Subordinated Voting Shares* of Acreage Holdings, Inc. (ACRG-U.CN) (ACRGF) (FSE:0ZV) ("Acreage" or the "Company"), today announced it will vote against Acreage's value-destroying proposed transaction with Canopy Growth Corporation (TSX:WEED.TO).

Key Points: 
  • SAN FRANCISCO, May 6, 2019 /PRNewswire/ -- Marcato Capital Management LP ("Marcato"), a San Francisco-based investment manager which manages funds that beneficially own approximately 2.7% of the outstanding Subordinated Voting Shares* of Acreage Holdings, Inc. (ACRG-U.CN) (ACRGF) (FSE:0ZV) ("Acreage" or the "Company"), today announced it will vote against Acreage's value-destroying proposed transaction with Canopy Growth Corporation (TSX:WEED.TO).
  • As a large Acreage shareholder, we will be voting against the proposed transaction with Canopy Growth Corporation ("Canopy") as we believe this is a value destructive transaction and not in the best interests of shareholders.
  • Accordingly, Marcato believes it is highly imprudent for Acreage to sell itself today at the proposed valuation, with so much unlocked growth and value embedded in the Company.
  • Shareholders of both companies appear to share Marcato's view that this is a great deal for Canopy and a terrible deal for Acreage.

Supreme Cannabis Third Quarter Earnings Release Scheduled for May 13, 2019

Retrieved on: 
Monday, May 6, 2019
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Drugs, OTC Markets Group, Legality of cannabis, Medicine, Aurora Cannabis, Canopy Growth

TORONTO, May 6, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that it will be providing its third quarter financial results for the three and nine months ended March 31, 2019 after markets close on May 13, 2019.

Key Points: 
  • TORONTO, May 6, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that it will be providing its third quarter financial results for the three and nine months ended March 31, 2019 after markets close on May 13, 2019.
  • The Supreme Cannabis Company, Inc. , is a global diversified portfolio of distinct cannabis companies, products and brands.
  • Certain statements made in this press release may constitute forward-looking information under applicable securities laws.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/supreme-cannabis-third-quarter-e...
    SOURCE The Supreme Cannabis Company, Inc.

Canopy Rivers congratulates TerrAscend on receiving its EU GMP certification and new distribution agreement

Retrieved on: 
Friday, May 3, 2019
Canopy Growth, CGC

TerrAscend also entered into a comprehensive sales and distribution agreement with iuvo Therapeutics GmbH ("iuvo"), a German pharmaceutical wholesaler.

Key Points: 
  • TerrAscend also entered into a comprehensive sales and distribution agreement with iuvo Therapeutics GmbH ("iuvo"), a German pharmaceutical wholesaler.
  • Only medical cannabis from EU GMP certified facilities, or the equivalent, may be sold in the EU.
  • "We applaud TerrAscend for achieving one of the highest and most rigorous levels of quality certification in the world," said Narbe Alexandrian, President of Canopy Rivers.
  • Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support.

CBD & Cannabis Companies Look to Build on Landmark Year

Retrieved on: 
Thursday, May 2, 2019
Medicine, Herbalism, Medicinal plants, Health, Antiemetics, Antioxidants, Medical cannabis, Pharmaceuticals policy, Cannabis, Canopy Growth, Decriminalization of non-medical cannabis in the United States

Moreover, the demand is prompting cannabis companies to ramp up operations in order to meet this demand.

Key Points: 
  • Moreover, the demand is prompting cannabis companies to ramp up operations in order to meet this demand.
  • As a result, cannabis companies are seeing tremendous revenue growth as the cannabis marketplace begins to take off.
  • For instance, In the second quarter of 2017, California's flower sales accounted for 55% of its total cannabis sales.
  • Moreover, 67% of Colorado's cannabis sales were made up of flower when legal sales began back in 2014.

CBD & Cannabis Companies Look to Build on Landmark Year

Retrieved on: 
Thursday, May 2, 2019
Medicine, Herbalism, Medicinal plants, Health, Antiemetics, Antioxidants, Medical cannabis, Pharmaceuticals policy, Cannabis, Canopy Growth, Decriminalization of non-medical cannabis in the United States

Moreover, the demand is prompting cannabis companies to ramp up operations in order to meet this demand.

Key Points: 
  • Moreover, the demand is prompting cannabis companies to ramp up operations in order to meet this demand.
  • As a result, cannabis companies are seeing tremendous revenue growth as the cannabis marketplace begins to take off.
  • For instance, In the second quarter of 2017, California's flower sales accounted for 55% of its total cannabis sales.
  • Moreover, 67% of Colorado's cannabis sales were made up of flower when legal sales began back in 2014.

ETFMG and Canopy Growth to Host Exclusive Cannabis Innovator Event at SALT 2019

Retrieved on: 
Thursday, April 25, 2019
Health, Alternative medicine, Biotechnology, Natural Resources, Agriculture, Professional services, Finance, Retail, Tobacco, Canopy Growth, Cannabis industry, Companies

View the full release here: https://www.businesswire.com/news/home/20190425005350/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20190425005350/en/
    Sam Masucci, CEO of ETFMG and featured speaker on cannabis investing at SALT, will join visionary and CEO of Canopy Growth Corporation, Bruce Linton, in a fireside chat followed by a live Q&A.
  • The week at SALT is all about thought leadership and it is only natural to host an innovator event that could further unlock the cannabis discussion.
  • The global cannabis industry is rapidly evolving, and as such both ETFMG and Canopy Growth Corporation keep education at the forefront of their trailblazing efforts and daily strategy.
  • If you are attending the SALT Conference and are interested in attending the Cannabis Innovator Breakfast, please register at http://bit.ly/etfmginnovatorevent .